Roche Pharmaceuticals has extended its partnership with Veeva Systems by adopting Veeva Vault CRM.

Vault CRM is part of the Vault CRM Suite of applications that provides the foundation for commercial execution. Veeva AI Agents for Vault CRM – Free Text Agent, Voice Agent, Pre-call Agent, and Media Agent – are planned for availability in December 2025.

“We’re excited to expand our partnership with Veeva by implementing Vault CRM across our global Pharma organization,” said Wafaa Mamilli, Roche’s chief digital and technology officer. “With data and AI at its core, Vault CRM will help us create more personalized interactions, giving our teams the insights to better support healthcare professionals and the patients they serve.”

“Roche and Veeva have partnered for many years,” said Veeva CEO Peter Gassner. “We are honored to extend our partnership to Vault CRM and bring the next generation of AI-enabled CRM to the global Roche Pharma field teams.”

Other global pharmaceutical companies that have adopted Veeva Vault CRM this year include, Gilead, Bristol Myers Squibb and Merck.